standard adjuvant therapy for adrenocortical carcinoma
Published 2 years ago • 117 plays • Length 1:11Download video MP4
Download video MP3
Similar videos
-
1:21
the rationale behind exploring adjuvant therapy in low-intermediate risk adrenocortical carcinoma
-
2:20
treatment options for recurrent post-operative adrenocortical carcinoma
-
0:39
current first-line therapies for patients with advanced adrenocortical carcinoma
-
1:11
current standard of adjuvant therapy in kidney cancer
-
0:35
adjuvo: first randomized trial of adjuvant mitotane in adrenocortical carcinoma patients
-
0:36
managing adrenocortical carcinoma with immunotherapies
-
2:43
elucidating the first-line therapy approach for the managing acc
-
1:19
adjuvo: adjuvant mitotane in patients with ac and low-intermediate risk of recurrence post-surgery
-
2:30
monarche: abemaciclib and adjuvant endocrine therapy for high-risk hr early breast cancer
-
0:31
global cooperation for the investigation of rare disease
-
2:24
enhancing diagnosis of adrenocortical carcinomas
-
6:40
first randomized trial on adjuvant mitotane in adrenocortical carcinoma patients: the adjuvo study.
-
1:56
optimizing adjuvant treatment in hr /her2- early breast cancer
-
4:35
what is a standard adjuvant chemotherapy regimen?
-
2:20
escalation of adjuvant therapy in hr breast cancer
-
1:08
novel approaches in treating merkel cell carcinoma
-
0:50
maintenance therapy for patients with advanced urothelial carcinoma
-
26:36
understanding clinical risk and the need for adjuvant therapy
-
0:46
dr. capitanio discusses adjuvant therapy for high-risk kidney cancer